Tenofovir Alafenamide Fumarate (TAF) Effect on Residual Intrathecal Immune Activation
Clinical trial NCT02771054 · COMPLETED
Trial details
- NCT number
- NCT02771054
- Sponsor
- Göteborg University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-02
- Primary completion
- 2018-07-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.